Corrigendum to "Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines" [Exp. Cell Res. 375 (2019) 92-99]

Affiliations

• ¹ Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany; Department of Pediatric and Adolescent Medicine, Gemeinschaftskrankenhaus Herdecke, Gerhard-Kienle-Weg 4, 58313, Herdecke, Germany.
• ² Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.
• ³ Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany.
• ⁴ Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany.
• ⁵ Department of Pediartric Oncology and Hematology, University Children's Hospital of Cologne, Medical Faculty, University of Cologne, Kerpener Str. 63, 50937, Cologne, Germany.
• ⁶ Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147 Essen, Germany.
• ⁷ Institute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45147, Essen, Germany. Electronic address: laura.steenpass@dsmz.de.